China Contract Research Organization (CRO) Industry Report, 2012-2013

Publisher Name :
Date: 01-Feb-2013
No. of pages: 65
Inquire Before Buying

Compared to Europe and America, China developed pharmaceutical CRO industry 40 years later, with domestic industrial players amounting to over 500, most of which are SMEs. In general, Chinese CRO market scale occupies only 7%-10% of the world’s total, and in 2011-2012 the CRO market size of China approximated RMB22-28 billion.

Considering huge potentials of Chinese phramceutical market, intensive talent resource, relatively low cost and rich spectrum of diseases, foreign enterprises are accelerating to expand CRO market there. Presently, world-renowned CRO companies including Quintiles, Covance, PPD, CRL and ICON have set foot in China by building new establishments and M&As. In China, homegrown leaders cover WuXi AppTec Co., Ltd., Shanghai-headquartered ShangPharma Corporation, and Hangzhou Tigermed Consulting, with the respective revenue in Jan.-Sep., 2012 hitting USD374 million, USD94.47 million and USD29.84 million, the combined proportion of 14% in China CRO market.

In an aim to realize resource sharing and improve overall competitiveness, some domestic pharmaceutical CRO enterprises seek joint development by setting up alliance. A case in point is ABO, which was established in 2005 merging nine research institutes including Academy of Military Medical Sciences, National Institutes for Food and Drug Control, and National Center of Biomedical Analysis, gathering three national engineering centers and seven national engineering technology centers, with sharable hi-tech resources valuing RMB1 billion. In 2012, ABO had 38 corporate members (including Sino Biological Inc. and Pharmaron), with the total area newly increasing by 40,000 sq meters to 270,000 sq meters or more and the total revenue growing by 28.6% year-on-year to over RMB1.8 billion which accounted for 6.4% in Beijing biomedical R&D service industry. And the revenue generated by international orders rose by 14.7% YoY to RMB780 million.

In Jan. 2013, JOINN Laboratories (Beijing), a member of ABO, took over the San Francisco-based R&D and production bases of Bayer, opening a new chapter for Chinese biomedical enterprises’ acquisition of worldwide R&D bases transnational businesses in overseas countries. And JOINN Laboratories is scheduled to lavish USD100 million to set up a 300-mu(1mu=666.7sq meters)US-based Join Innovation Park, in an attempt to provide business incubator, technical support, international cooperation and other services for small-and medium-sized biomedical innovative enterprises in Silicon Valley and China.

The report highlights the followings:


  • international market, domestic macro- environment and polices, laws and regulations of China CRO industry;

  • status quo, market scale, competition pattern and development prediction of China CRO industry;

  • Operation, CRO business and development dynamics in China of six foreign and five domestic industrial players.

China Contract Research Organization (CRO) Industry Report, 2012-2013

Table of Contents

1. Overview of CRO Industry
1.1 Definition & Classification
1.2 Industry Background

2. Development Environment of CRO Industry in China
2.1 International Environment
2.2 Industry Environment
2.3 Policy Environment

3. Market Analysis of CRO Industry in China
3.1 Status Quo
3.2 Market Size
3.3 Competition Pattern
3.4 Regional Market
3.4.1 Beijing
3.4.2Shanghai
3.4.3 Chengdu
3.5 Prospects

4?Key CRO Enterprises Worldwide
4.1 Covance Inc.
4.1.1 Profile
4.1.2 Operation
4.1.3 Revenue Structure
4.1.4 Business in China
4.2 PAREXEL International
4.2.1 Profile
4.2.2 Operation
4.2.3 Revenue Structure
4.2.4 Business in China
4.3 PPD
4.3.1 Profile
4.3.2 Operation
4.3.3 Business in China
4.4 Quintiles Transnational Corp.
4.4.1 Profile
4.4.2 Business in China
4.5 Charles River Laboratories International, Inc.
4.5.1 Profile
4.5.2 Operation
4.5.3 Revenue Structure
4.5.4 Business in China
4.6 Asymchem Inc.
4.6.1 Profile
4.6.2 Business in China

5?Key CRO Enterprises in China
5.1 WuXi AppTec Co., Ltd.
5.1.1 Profile
5.1.2 Operation
5.1.3 Revenue Structure
5.1.4 Development Trend and Prospects
5.2 ShangPharma Corporation
5.2.1 Profile
5.2.2 Operation
5.2.3 Revenue Structure
5.2.4 Development Trend and Prospects
5.3 Venturepharm Laboratories Ltd.
5.3.1 Profile
5.3.2 Operation
5.3.3 Revenue Structure
5.3.4 Development Trend and Prospects
5.4 Tigermed Consulting Co., Ltd
5.4.1 Profile
5.4.2 Operation
5.4.3 Revenue Structure
5.4.4 Gross Margin
5.4.5 Clients and Suppliers
5.4.6 Development Trend and Prospects
5.5 Sundia MediTech Co., Ltd."

List of Charts

Classification of CRO
Global CRO Market Size and Growth Rate, 2007-2012
Global Key CRO Organizations and Their Business
Total Industrial Sales and Growth Rate of China’s Pharmaceutical Manufacturing, 2008-2012
Total Industrial Sales of China’s Bio-chemical Pharmaceutical Manufacturing, 2008-2012
Chinese CRO Market Size and Growth Rate, 2007-2012
Classification of Chinese CRO Companies (by Business)
Key M&A Cases of CRO Industry in China, 2007-2011
Regional Distribution of Leading Foreign CROs in China
Revenue and YoY Growth Rate of ABO, 2010-2012
Sponsors of CRO in Zhonguancun (Listed in No Particular Order)
Platform Edge of Shanghai Pharma Engine
Major CRO Enterprises of Shanghai Pharma Engine
Revenue and Operating Profit of Covance, 2009-2012
Revenue of Covance by Business, 2010-2012
Revenue and Operating Profit of PAREXEL, 2009-2012
Revenue of PAREXEL by Business, 2009-2012
Revenue of PAREXEL by Region Worldwide, 2009-2012
Revenue of PPD, 2007-2010
Corporate Advantages of Excel PharmaStudies, Inc.
Revenue and Operating Profit of CRL, 2009-2012
Revenue Breakdown of CRL by Business, 2009-2012
Asymchem Inc’s Companies and Main Businesses in China
Operation of Asymchem Inc.(Tianjin), 2008 & Jan.2009-May, 2009
Branch Distribution of WuXi AppTec Co., Ltd
Revenue and Gross Margin of WuXi AppTec Co., Ltd, 2008-2012
Main Businesses of WuXi AppTec Co., Ltd
Revenue of WuXi AppTec Co., Ltd by Business, 2010-2012
Big Events of WuXi AppTec Co., Ltd, 2011-2012
Revenue and Gross Margin of WuXi AppTec Co., Ltd, 2011-2015E
Distribution of Subsidiaries of ShangPharma Corporation
Four R&D Bases of ShangPharma Corporation
Revenue and Gross Profit of ShangPharma Corporation, 2008-2012
Revenue Breakdown of ShangPharma Corporation by Business, 2009-2011
Shareholding (Joint-stock) Companies of Venturepharm Laboratories Ltd
Revenue and Gross Profit of Venturepharm Laboratories Ltd, 2007-2011
Revenue of Venturepharm Laboratories Ltd by Business, 2010-2011
Number of Cases of Venturepharm laboratories Approved by SFDA, 2002-2011
Seven Subsidiaries and Business Distribution of Tigermed Consulting Co., Ltd
Domestic and Foregin Customer Distribution of Tigermed by Region
Revenue and Profit of Tigermed, 2009-2012
New Contract Value and Average Contract Value of New Contracts of Tigermed, 2009-2011
New Contract Number and Value of Tigermed by Business, 2009-2011
Operating Revenue and Operating Cost of Tigermed by Business, 2009-2011
Revenue Breakdown of Tigermed by Region, 2009-2011
Revenue and Proportion from Clinical Test Technical Service Business of Tigermed, 2009-2011
Consolidated Gross Margin of Tigermed, 2009-2011
Gross Margin of Tigermed by Business, 2009-2011
Name List and Revenue Contribution of Tigermed’s Top 5 Clients, 2009-2011
Name list and Procurement of Tigermed’s Top 5 Suppliers,2009-2011
Number of Clinical Research Projects of Tigermed by Business
Clinical Research Projects of Tigermed by Disease
IPO Investment Projects of Tigermed
Business Layout of Tigermed after Production of Fundraising Projects

  • Overview of Global and Chinese 3D Printing Market 2015-2020
    ‘2015 3D Printing Industry Report -Global and Chinese Market’ is a comprehensive research report that describes the scope of the Global and Chinese 3D printing industry, analyzing the end-users behavior and the latest industry trends. Also, the report evaluates the growth prospects and the up-coming opportunities in the industry over the forecast period of 2015-2020. [...]
  • Schottky Diode Industry Research – 2015 Global and Chinese Market Overview
    ‘2015 Schottky Diode Industry Report – Global and Chinese Market Scenario’ is a top-notch research report, delivering premium industry insights and explanations of complex business scenarios. The report systematically articulates various growth prospects and current market challenges being faced by the existing industry players. The research report also drafts a meticulous business forecast that provides [...]
  • Codeine (CAS 76-57-3) Industry Research Report – 2009-2019 Market Forecast
    ‘Global and Chinese Codeine (CAS 76-57-3) Industry, 2009-2019 Market Research Report’, a systematically structured research report, that aims to deliver a detailed understanding of vivid market scenarios prevalent in the Codeine (CAS 76-57-3) industry to the user.  The report articulates various sections that thoroughly describe all key-aspects of the Codeine (CAS 76-57-3) industry. The report [...]
  • Global and Chinese Mainframe Banking Industry 2015 Outlook
    2015 Banks Mainframe Industry Report -Global and Chinese Market is a detailed market research report, delivering premium industry insights and analyzing the growth prospects of the industry over the forecast period of 2015-2020. The systematically structured sections of the research report, aims at conveying a strong business understanding to the user, enhancing the decision making [...]
  • Global and Chinese Market Situation of Milk Infant Formula Industry Over the Period of 2009-2019
    ‘Market Research Report on Global and Chinese Milk Infant Formula Industry, 2009-2019’ a comprehensive market study, that analyses various market landscape and key-aspects of the industry, delivering premium business insight and thorough understanding of the Global and Chinese market conditions to the user. Industry experts have methodologically structured the elaborative sections of the research report, [...]
    • The Oil Drilling Rig Industry
    • The Oil Drilling Rig Industry is characterized with a few typical work specific to this industry only. The work begins with the search for new oil basins or construction of wells. During this time the services of drilling contractors and se…

    • HER2-Negative Breast Cancer’s Therapeutic Market
    • HER2-Negative Breast Cancer is the most common form of cancer occurring in women. The long term survival of patients diagnosed with HER2-Negative Breast Cancer depends solely on its early detection as till now there is no medicine that can …

    • The Market of Plate Heat Exchanger
    • Plate heat exchanger is not only very useful but its also easy to maintain, its compact design makes it more efficient, the product is highly cost-efficient and also the materials of this product are easily available. There are some limitat…

    • The Industry of Binding Machines
    • Binding of books and papers is one of the most important aspect of buying and selling books and thus the demand of binding machines. There are different kinds of binding machines available in the market. The binding type determines the bind…

    • The Boom In Women Infertility Market
    • Infertility is an abnormality in the regular functioning of the human reproductive system. Anyone of male or female might be suffering from this issue. Infertility in woman is caused by either a genetical factor or factors such as aging or …

  • Personalized Medicine
    Published: 01-Aug-2007        Price: US 1999 Onwards        Pages: 87
    Personalized medicine and pharmacogenomics are inextricably linked. Pharmacogenomics is the use of genetic variations (such as SNPs, gene expression variability, or other molecular signatures) to understand and correlate with differential response to pharmaceutical agents (drugs). Pharmacogenomics can be deployed clinically to stratify patients into responders and non-responders and this practice is termed personalized medicine. The purpose of this TriMark Publications report is to describe the ......
  • Indian Pharmaceutical Industry
    Published: 01-Jul-2008        Price: US 1999 Onwards        Pages: 207
    The purpose of this TriMark Publications study is to describe the specific segment of the pharmaceutical market sector called the Indian pharmaceutical industry. This sector includes all of the generally-accepted pharmaceutical manufacturing activities that are currently used today, including the bulk drug industry, formulations and major therapeutic segments. It examines these clinical supplies as utilized in hospitals, clinics and doctor's offices. The principal objectives of this analysis are......
  • The Pharmaceutical Industry 2009 - The Key R&D Trends Impacting New Product Development
    Published: 15-Apr-2009        Price: US 3900 Onwards        Pages: 46
    The Pharmaceutical Industry 2009 - The Key R&D Trends Impacting New Product Development Summary Despite the current economic downturn, pharmaceutical research and development spending continues to play a vital role in the pharmaceutical industry. Recent trends indicate a consolidation of efforts through numerous acquisitions, both intra-pharmaceutical as well as purchases of biotechs by big pharma. In addition, pharmaceutical companies are narrowing the......
  • The Obama Administration and the Pharmaceutical Industry - Overview of the 2009 Recovery Act and the 2010 Federal Budget
    Published: 15-Jun-2009        Price: US 3900 Onwards        Pages: 54
    The Obama Administration and the Pharmaceutical Industry - Overview of the 2009 Recovery Act and the 2010 Federal Budget Summary President Obama has made healthcare reform one of his administration's top priorities. Towards this goal, several billion dollars have been provided through the Recovery Act and 2010 Budget for initiatives that are intended to make the US healthcare system safer and more cost-effective. These include - - conducting comparative effec......
  • The Economy and the Pharmaceutical Industry - Adherence to Drug Treatments and How the Current Economic Environment is Affecting Patients' Treatment Choices
    Published: 15-Nov-2009        Price: US 3900 Onwards        Pages: 57
    The Economy and the Pharmaceutical Industry - Adherence to Drug Treatments and How the Current Economic Environment is Affecting Patients' Treatment Choices Summary The ongoing US recession is affecting consumers' behavior in the healthcare market. The rising unemployment rate means that fewer individuals are covered under generous employer sponsored health insurance plans. Many people who lose their jobs also lose their ability to cover the costs of healthcare, inc......
  • The Pharmaceutical Year in Review 2009 - Industry Trends and Lessons Learned
    Published: 15-Dec-2009        Price: US 3900 Onwards        Pages: 67
    The Pharmaceutical Year in Review 2009 - Industry Trends and Lessons Learned Summary 2009 has been a turbulent year for the global economy and the increasing interconnectivity of business has amplified its impact on the pharmaceutical industry. As a result of the global recession, the pharmaceutical industry has seen a greater urgency to adapt its ways in order to continue to sustain any substantial growth. Several key events & trends have been seen ove......
  • The Future of High Potency Active Pharmaceutical Ingredients (HPAPIs), Market Forecasts and Growth Opportunities to 2015 - Growing Demand Drives Investment in Capacity
    Published: 15-Mar-2010        Price: US 1000 Onwards        Pages: 54
    Report Summary GBI Research has released “The Future of High Potency Active Pharmaceutical Ingredients (HPAPIs), Market Forecasts and Growth Opportunities to 2015 - Growing Demand Drives Investment in Capacity”. The study, which is an offering from the company’s Chemicals Research Group, provides in-depth analysis of the global HPAPIs market with revenue forecasts up to 2015. Revenue forecasts, which include historical statistics of the market, are provided for the major regi......
  • Emerging Market Strategies - Mapping the opportunities for pharmaceutical expansion
    Published: 15-Apr-2010        Price: US 3900 Onwards        Pages: 54
    Emerging Market Strategies - Mapping the opportunities for pharmaceutical expansion Summary With a variety of factors impacting pharmaceutical growth in the traditional markets (the US, 5EU and Japan) - price controls, moves towards generics, healthcare reform, market saturation - the emerging markets (EMs) hold increasing potential to drive future product sales and overall company revenues. The different situations which exist within each emerging mark......
  • Active Pharmaceutical Ingredients (APIs) Market to 2015 - Rise in the Generic and Biotech Sector will Sustain Growth
    Published: 01-Oct-2010        Price: US 1000 Onwards        Pages: 114
    Report Summary GBI Research has released its Chemical research, “Active Pharmaceutical Ingredients (APIs) Market to 2015 - Rise in the Generic and Biotech Sector will Sustain Growth”. The report provides a detailed insight into the global Active Pharmaceutical Ingredients (APIs) market. The research presents detailed analysis and forecasts of the major economic and market trends affecting the API markets in major regions of the world. The report contains market forecasts, pro......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs